Logo image of JBGS

JBG SMITH PROPERTIES (JBGS) Stock Fundamental Analysis

NYSE:JBGS - New York Stock Exchange, Inc. - US46590V1008 - REIT - Currency: USD

14.63  -0.04 (-0.27%)

After market: 14.63 0 (0%)

Fundamental Rating

2

Overall JBGS gets a fundamental rating of 2 out of 10. We evaluated JBGS against 130 industry peers in the Diversified REITs industry. Both the profitability and financial health of JBGS have multiple concerns. JBGS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year JBGS has reported negative net income.
In the past year JBGS had a positive cash flow from operations.
JBGS had negative earnings in 4 of the past 5 years.
Each year in the past 5 years JBGS had a positive operating cash flow.
JBGS Yearly Net Income VS EBIT VS OCF VS FCFJBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -2.91%, JBGS is not doing good in the industry: 77.69% of the companies in the same industry are doing better.
With a Return On Equity value of -8.07%, JBGS is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 0.11%, JBGS is not doing good in the industry: 87.69% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for JBGS is below the industry average of 3.19%.
Industry RankSector Rank
ROA -2.91%
ROE -8.07%
ROIC 0.11%
ROA(3y)-0.99%
ROA(5y)-1.07%
ROE(3y)-2.88%
ROE(5y)-2.7%
ROIC(3y)0.37%
ROIC(5y)N/A
JBGS Yearly ROA, ROE, ROICJBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6 -8

1.3 Margins

Looking at the Operating Margin, with a value of 1.25%, JBGS is doing worse than 87.69% of the companies in the same industry.
In the last couple of years the Operating Margin of JBGS has declined.
JBGS's Gross Margin of 50.03% is on the low side compared to the rest of the industry. JBGS is outperformed by 77.69% of its industry peers.
JBGS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.25%
PM (TTM) N/A
GM 50.03%
OM growth 3YN/A
OM growth 5Y-29.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5Y-0.13%
JBGS Yearly Profit, Operating, Gross MarginsJBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JBGS is destroying value.
JBGS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for JBGS has been reduced compared to 5 years ago.
JBGS has a worse debt/assets ratio than last year.
JBGS Yearly Shares OutstandingJBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
JBGS Yearly Total Debt VS Total AssetsJBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.10, we must say that JBGS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.10, JBGS is doing worse than 72.31% of the companies in the same industry.
JBGS has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
JBGS has a Debt to Equity ratio (1.42) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z 0.1
ROIC/WACC0.02
WACC6.6%
JBGS Yearly LT Debt VS Equity VS FCFJBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

JBGS has a Current Ratio of 1.95. This is a normal value and indicates that JBGS is financially healthy and should not expect problems in meeting its short term obligations.
JBGS has a Current ratio of 1.95. This is in the better half of the industry: JBGS outperforms 76.92% of its industry peers.
A Quick Ratio of 1.95 indicates that JBGS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.95, JBGS is doing good in the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.95
JBGS Yearly Current Assets VS Current LiabilitesJBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for JBGS have decreased strongly by -129.69% in the last year.
Looking at the last year, JBGS shows a decrease in Revenue. The Revenue has decreased by -9.43% in the last year.
JBGS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.32% yearly.
EPS 1Y (TTM)-129.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.71%
Revenue 1Y (TTM)-9.43%
Revenue growth 3Y-4.8%
Revenue growth 5Y-3.32%
Sales Q2Q%-26.53%

3.2 Future

The Earnings Per Share is expected to decrease by -13.91% on average over the next years. This is quite bad
The Revenue is expected to grow by 1.62% on average over the next years.
EPS Next Y-31.14%
EPS Next 2Y-13.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.63%
Revenue Next 2Y1.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBGS Yearly Revenue VS EstimatesJBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
JBGS Yearly EPS VS EstimatesJBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBGS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBGS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBGS Price Earnings VS Forward Price EarningsJBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBGS indicates a slightly more expensive valuation: JBGS is more expensive than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.35
JBGS Per share dataJBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as JBGS's earnings are expected to decrease with -13.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.91%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

JBGS has a Yearly Dividend Yield of 4.69%, which is a nice return.
Compared to an average industry Dividend Yield of 16.86, JBGS is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.51, JBGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.69%

5.2 History

The dividend of JBGS decreases each year by -7.39%.
JBGS has been paying a dividend for over 5 years, so it has already some track record.
The dividend of JBGS decreased recently.
Dividend Growth(5Y)-7.39%
Div Incr Years1
Div Non Decr Years1
JBGS Yearly Dividends per shareJBGS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of JBGS are negative and hence is the payout ratio. JBGS will probably not be able to sustain this dividend level.
JBGS's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-42.47%
EPS Next 2Y-13.91%
EPS Next 3YN/A
JBGS Yearly Income VS Free CF VS DividendJBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

More info and screens

JBG SMITH PROPERTIES

NYSE:JBGS (4/25/2025, 4:34:50 PM)

After market: 14.63 0 (0%)

14.63

-0.04 (-0.27%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)04-29 2025-04-29
Inst Owners96.23%
Inst Owner Change-0.08%
Ins Owners0.05%
Ins Owner Change0.03%
Market Cap1.20B
Analysts42.5
Price Target16.32 (11.55%)
Short Float %13%
Short Ratio8.97
Dividend
Industry RankSector Rank
Dividend Yield 4.69%
Yearly Dividend0.69
Dividend Growth(5Y)-7.39%
DP-42.47%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-37.7%
Min EPS beat(2)-85.76%
Max EPS beat(2)10.36%
EPS beat(4)3
Avg EPS beat(4)1.94%
Min EPS beat(4)-85.76%
Max EPS beat(4)47.71%
EPS beat(8)5
Avg EPS beat(8)3.83%
EPS beat(12)7
Avg EPS beat(12)107.87%
EPS beat(16)10
Avg EPS beat(16)79.24%
Revenue beat(2)0
Avg Revenue beat(2)-16.77%
Min Revenue beat(2)-17.51%
Max Revenue beat(2)-16.03%
Revenue beat(4)0
Avg Revenue beat(4)-13.34%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)-1.2%
Revenue beat(8)1
Avg Revenue beat(8)-9.48%
Revenue beat(12)1
Avg Revenue beat(12)-8.17%
Revenue beat(16)3
Avg Revenue beat(16)-3.03%
PT rev (1m)0%
PT rev (3m)3.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-15.24%
EPS NY rev (3m)-15.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.19
P/FCF N/A
P/OCF 9.28
P/B 0.66
P/tB 0.68
EV/EBITDA 16.35
EPS(TTM)-1.47
EYN/A
EPS(NY)-1.93
Fwd EYN/A
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)1.58
OCFY10.78%
SpS6.67
BVpS22.05
TBVpS21.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -8.07%
ROCE 0.14%
ROIC 0.11%
ROICexc 0.12%
ROICexgc 0.12%
OM 1.25%
PM (TTM) N/A
GM 50.03%
FCFM N/A
ROA(3y)-0.99%
ROA(5y)-1.07%
ROE(3y)-2.88%
ROE(5y)-2.7%
ROIC(3y)0.37%
ROIC(5y)N/A
ROICexc(3y)0.39%
ROICexc(5y)N/A
ROICexgc(3y)0.4%
ROICexgc(5y)N/A
ROCE(3y)0.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-29%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.03%
OM growth 3YN/A
OM growth 5Y-29.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5Y-0.13%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA 11.58
Cap/Depr 101.41%
Cap/Sales 39.84%
Interest Coverage 0.06
Cash Conversion 58.32%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.95
Altman-Z 0.1
F-Score4
WACC6.6%
ROIC/WACC0.02
Cap/Depr(3y)148.41%
Cap/Depr(5y)152.09%
Cap/Sales(3y)54.34%
Cap/Sales(5y)56.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.71%
EPS Next Y-31.14%
EPS Next 2Y-13.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.43%
Revenue growth 3Y-4.8%
Revenue growth 5Y-3.32%
Sales Q2Q%-26.53%
Revenue Next Year-3.63%
Revenue Next 2Y1.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-85.68%
EBIT growth 3YN/A
EBIT growth 5Y-31.53%
EBIT Next Year2599.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.44%
OCF growth 3Y-15.91%
OCF growth 5Y-5.75%